2-(2-Chlorophenyl)-3-oxo-3-(pyridin-3-yl)propanenitrile

Catalog No. :
ACJCNX053
CAS No. :
1291439-19-4
Molecular Formula :
C14H9ClN2O
Molecular Weight :
256.69

IUPAC Name:2-(2-chlorophenyl)-3-oxo-3-(pyridin-3-yl)propanenitrile

2-(2-Chlorophenyl)-3-oxo-3-(pyridin-3-yl)propanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$235.00Login to see priceInquiryInquiry
100mg95%$338.00Login to see priceInquiryInquiry
250mg95%$475.00Login to see priceInquiryInquiry
1g95%$944.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Chlorophenyl)-3-oxo-3-(pyridin-3-yl)propanenitrile
IUPAC Name2-(2-chlorophenyl)-3-oxo-3-(pyridin-3-yl)propanenitrile
MDL No.-
Molecular FormulaC14H9ClN2O
Molecular Weight256.69
SMILESN#CC(C1=CC=CC=C1Cl)C(C2=CC=CN=C2)=O
InChI KeyVQEZQDAGLIYQHN-UHFFFAOYSA-N
Synonym3-Pyridinepropanenitrile, α-(2-chlorophenyl)-β-oxo-;2-(2-Chlorophenyl)-3-oxo-3-(pyridin-3-yl)propanenitrile
CAS No.1291439-19-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJCNX053 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJCNX053 route product structure diagram
    ACJCNX0531291439-19-4
Inquiry

2. ACJCNX053 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACJCNX053 route product structure diagram
    ACJCNX0531291439-19-4
Inquiry

Comments (0)